<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03292523</url>
  </required_header>
  <id_info>
    <org_study_id>2016_68</org_study_id>
    <secondary_id>2017-A01542-51</secondary_id>
    <nct_id>NCT03292523</nct_id>
  </id_info>
  <brief_title>Work Productivity in Hyperventilation Syndrome</brief_title>
  <acronym>WHY</acronym>
  <official_title>Work Productivity in Hyperventilation Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hyperventilation syndrome is associated with impaired quality of life. The aim of the study
      is to assess the relationship between work productivity, including absenteeism and
      presenteeism, and the severity of hyperventilation syndrome
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Association between the WPAI score and the Nijmegen score</measure>
    <time_frame>At the time of diagnosis (Baseline)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between the WPAI score and dyspnea scales</measure>
    <time_frame>At the time of diagnosis (Baseline)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between the WPAI score and quality of life scores</measure>
    <time_frame>At the time of diagnosis (Baseline)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between the WPAI score and PaCO2</measure>
    <time_frame>At the time of diagnosis (Baseline)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Association between the WPAI score and the Cognitive Failure Questionnaire score</measure>
    <time_frame>At the time of diagnosis (Baseline)</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hyperventilation Syndrome</condition>
  <arm_group>
    <arm_group_label>Hyperventilation syndrome</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire</intervention_name>
    <description>Work Productivity and Activity Impairment (WPAI) Multidimensional Dyspnea Profile (MDP) Baseline Dyspnea Index (BDI), MOS-SF36, Hospital Anxiety Depression (HAD) Cognitive Failure Questionnaire (CFQ).</description>
    <arm_group_label>Hyperventilation syndrome</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with confirmed hyperventilation syndrome, virgin of any treatment.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Holders of employment contracts for at least 8 days

          -  Diagnosis of hyperventilation syndrome confirmed by:

        Compatible symptoms and at least two symptoms reproduced by the hyperventilation challenge
        test: Nijmegen's score&gt; 23 ; Demonstration of alveolar hyperventilation ( Either on rest
        blood and / or at rest (PaCO2 at rest &lt;36 mmHg and D (A-a) O2 normal; Either during the HV
        test (increased recovery time of the basic PETCO2 after voluntary hyperventilation (greater
        than 5 minutes)

        Exclusion Criteria:

          -  Existence of another chronic pulmonary disease (asthma, bronchial dilation, COPD,
             diffuse interstitial pneumonia, neuromuscular pathology ...) or cardiac (rhythm
             disorder, ischemic heart disease ...) which can participate in dyspnea

          -  Psychiatric illness / psychotropic treatment

          -  Pregnancy

          -  Patient already included in a clinical research protocol involving new therapeutics
             may not be included in this protocol

          -  Specific physiotherapy or previous training
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cécile Chenivesse, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cécile Chenivesse, MD</last_name>
    <phone>3.20.44.59.48</phone>
    <phone_ext>+33</phone_ext>
    <email>cecile.chenivesse@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Calmette,CHU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Cecile Chenivesse</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2017</study_first_submitted>
  <study_first_submitted_qc>September 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2017</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hyperventilation syndrome</keyword>
  <keyword>Work productivity</keyword>
  <keyword>Absenteeism</keyword>
  <keyword>Presenteeism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Hyperventilation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

